MARKET

LQDA

LQDA

Liquidia Corporation
NASDAQ
34.03
-1.23
-3.49%
After Hours: 33.60 -0.43 -1.26% 19:04 12/17 EST
OPEN
35.03
PREV CLOSE
35.26
HIGH
35.26
LOW
33.95
VOLUME
910.25K
TURNOVER
--
52 WEEK HIGH
35.54
52 WEEK LOW
10.37
MARKET CAP
2.96B
P/E (TTM)
-23.7905
1D
5D
1M
3M
1Y
5Y
1D
Liquidia’s Phase 3 Study: Pioneering Treatment for Pulmonary Hypertension
TipRanks · 15h ago
Notable Tuesday Option Activity: LQDA, JBL, MGNI
NASDAQ · 1d ago
Take the Zacks Approach to Beat the Markets: Liquidia, Western Digital & Johnson & Johnson in Focus
NASDAQ · 2d ago
Weekly Report: what happened at LQDA last week (1208-1212)?
Weekly Report · 2d ago
Using Quantitative Signal Data For Portfolio Management
Seeking Alpha · 12/09 09:20
Weekly Report: what happened at LQDA last week (1201-1205)?
Weekly Report · 12/08 09:13
Weekly Report: what happened at LQDA last week (1124-1128)?
Weekly Report · 12/01 09:12
Wall Street Analysts See a 51.15% Upside in Liquidia Corporation (LQDA): Can the Stock Really Move This High?
NASDAQ · 11/24 14:55
More
About LQDA
Liquidia Corporation is a biopharmaceutical company. The Company is focused on the development, manufacture and commercialization of products that address unmet patient needs, with a focus directed towards rare cardiopulmonary diseases, such as pulmonaryarterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The Company operate through its wholly owned operating subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Its proprietary PRINT technology is a particle engineering platform, which enable precise production of uniform drug particles. Its lead product candidate is YUTREPIA for the treatment of PAH and PH-ILD. YUTREPIA is an inhaled dry powder formulation of treprostinil designed with PRINT to improve the therapeutic profile of treprostinil by enhancing deep lung delivery while using a convenient, dry-powder inhaler (DPI) and by achieving higher dose levels than the labeled doses of current inhaled therapies.

Webull offers Liquidia Corp stock information, including NASDAQ: LQDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LQDA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LQDA stock methods without spending real money on the virtual paper trading platform.